General scientific guidance for stakeholders on health claim applications: (Scientific Opinion)

Research output: Contribution to journal › Journal article › Commissioned › peer-review

Standard

General scientific guidance for stakeholders on health claim applications : (Scientific Opinion). / EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA).

In: E F S A Journal, Vol. 14, No. 1, 4367, 18.01.2016.

Research output: Contribution to journal › Journal article › Commissioned › peer-review

Harvard

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2016, 'General scientific guidance for stakeholders on health claim applications: (Scientific Opinion)', E F S A Journal, vol. 14, no. 1, 4367. https://doi.org/10.2903/j.efsa.2016.4367

APA

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2016). General scientific guidance for stakeholders on health claim applications: (Scientific Opinion). E F S A Journal, 14(1), [4367]. https://doi.org/10.2903/j.efsa.2016.4367

Vancouver

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). General scientific guidance for stakeholders on health claim applications: (Scientific Opinion). E F S A Journal. 2016 Jan 18;14(1). 4367. https://doi.org/10.2903/j.efsa.2016.4367

Author

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). / General scientific guidance for stakeholders on health claim applications : (Scientific Opinion). In: E F S A Journal. 2016 ; Vol. 14, No. 1.

Bibtex

@article{68bc5bddfc5d4b00a54e8d3f0183d5d0,
title = "General scientific guidance for stakeholders on health claim applications: (Scientific Opinion)",
abstract = "The European Food Safety Authority (EFSA) asked the Panel on Dietetic Products Nutrition and Allergies (NDA) to update the General guidance for stakeholders on the evaluation of Article 13.1, 13.5 and 14 health claims published in March 2011. Since then, the NDA Panel has completed the evaluation of Article 13.1 claims except for claims put on hold by the European Commission, and hasevaluated additional health claim applications submitted pursuant to Articles 13.5, 14 and also 19. In addition, comments received from stakeholders indicate that general issues that are common to all health claims need to be further clarified and addressed. This guidance document aims to explain the general scientific principles applied by the NDA Panel for the evaluation of all health claims and outlines a series of steps for the compilation of applications. The general guidance document represents the views of the NDA Panel based on the experience gained to date with the evaluation of health claims, and it may be further updated, as appropriate, when additional issues are addressed. ",
keywords = "Faculty of Science, Guidance, Health claims, General principles, Scientific aspects, Applications",
author = "{EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)} and Sj{\"o}din, {Anders Mikael}",
note = "EFSA 2016 4367",
year = "2016",
month = jan,
day = "18",
doi = "10.2903/j.efsa.2016.4367",
language = "English",
volume = "14",
journal = "E F S A Journal",
issn = "1831-4732",
publisher = "European Food Safety Authority (E F S A)",
number = "1",

}

RIS

TY - JOUR

T1 - General scientific guidance for stakeholders on health claim applications

T2 - (Scientific Opinion)

AU - EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

AU - Sjödin, Anders Mikael

N1 - EFSA 2016 4367

PY - 2016/1/18

Y1 - 2016/1/18

N2 - The European Food Safety Authority (EFSA) asked the Panel on Dietetic Products Nutrition and Allergies (NDA) to update the General guidance for stakeholders on the evaluation of Article 13.1, 13.5 and 14 health claims published in March 2011. Since then, the NDA Panel has completed the evaluation of Article 13.1 claims except for claims put on hold by the European Commission, and hasevaluated additional health claim applications submitted pursuant to Articles 13.5, 14 and also 19. In addition, comments received from stakeholders indicate that general issues that are common to all health claims need to be further clarified and addressed. This guidance document aims to explain the general scientific principles applied by the NDA Panel for the evaluation of all health claims and outlines a series of steps for the compilation of applications. The general guidance document represents the views of the NDA Panel based on the experience gained to date with the evaluation of health claims, and it may be further updated, as appropriate, when additional issues are addressed.

AB - The European Food Safety Authority (EFSA) asked the Panel on Dietetic Products Nutrition and Allergies (NDA) to update the General guidance for stakeholders on the evaluation of Article 13.1, 13.5 and 14 health claims published in March 2011. Since then, the NDA Panel has completed the evaluation of Article 13.1 claims except for claims put on hold by the European Commission, and hasevaluated additional health claim applications submitted pursuant to Articles 13.5, 14 and also 19. In addition, comments received from stakeholders indicate that general issues that are common to all health claims need to be further clarified and addressed. This guidance document aims to explain the general scientific principles applied by the NDA Panel for the evaluation of all health claims and outlines a series of steps for the compilation of applications. The general guidance document represents the views of the NDA Panel based on the experience gained to date with the evaluation of health claims, and it may be further updated, as appropriate, when additional issues are addressed.

KW - Faculty of Science

KW - Guidance

KW - Health claims

KW - General principles

KW - Scientific aspects

KW - Applications

U2 - 10.2903/j.efsa.2016.4367

DO - 10.2903/j.efsa.2016.4367

M3 - Journal article

VL - 14

JO - E F S A Journal

JF - E F S A Journal

SN - 1831-4732

IS - 1

M1 - 4367

ER -

ID: 187626996